Post
Forxiga flunks primary endpoint in DICTATE-AHF trial
At this year’s European Society of Cardiology (ESC) Congress, research found that early initiation of Forxiga (dapagliflozin) failed to improve …
Can steatosis-associated fibrosis estimator scores improve diagnosis of NAFLD/NASH?
Non-alcoholic fatty liver disease (NAFLD), a result of excess fat buildup in the liver, is one of the most common …
Pain points: Unsolved recruitment and trial design issues in pain clinical trials
Pain is universal, yet it is highly individual and subjective. As such, clinical trials investigating pain face multiple challenges. Even …
Mendus shows early comparability data for its universal cancer vaccine
Mendus has announced that the immune response triggered by vididencel was comparable for patients with acute myeloid leukaemia (AML) and …
SpyBiotech submits CTA to UK MHRA for HCMV vaccine
SpyBiotech has submitted a clinical trial application (CTA) to the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for the …
Relmada reports positive results from trial of MDD therapy
Relmada Therapeutics has reported positive safety and efficacy results from the long-term Phase III REL-1017-310 trial evaluating REL-1017 in patients …
Signal: Fresh Tracks nears end of operations with plans for dissolution
Fresh Tracks Therapeutics has announced a proposed dissolution and liquidation of the company in “an orderly fashion” as stated by …
Vir Biotechnology doses first subject in HIV therapy trial
Vir Biotechnology has dosed the first patient in the Phase I HVTN 142 clinical trial of the new T cell …
Regulus reports positive Phase Ib data for kidney disease treatment
Regulus Therapeutics has reported positive topline data from the first cohort of its Phase Ib multiple-ascending dose (MAD) clinical trial of RGLS8429 …
Will there ever be a cure for Alzheimer’s disease?
It has been over 100 years since Dr Alois Alzheimer reported “a peculiar severe disease process of the cerebral cortex” …
Fungal Disease Awareness Week: novel drugs essential to tackle antifungal resistance
18-22 September is Fungal Disease Awareness Week (FDAW) in the US, in which the Centers for Disease Control and Prevention …
Signal: UK NHS pay row intensifies as doctors launch joint strike
UK consultants and junior doctors walked out today (20 September) for joint strike action, the first in the National Health …
Medidata unveils new solution to boost clinical trial diversity
Medidata has unveiled a new solution called the Medidata Diversity Program, which aims to enhance diversity, equity, and inclusion in …
Taysha suspends its lead gene therapy programme after FDA feedback
Taysha Gene Therapies has discontinued its TSHA-120 development for gene therapy following a Type C meeting with the US Food …
1ST Biotherapeutics and Merck to assess cancer combination treatment
1ST Biotherapeutics has signed a clinical trial collaboration and supply agreement with Merck & Co (MSD) to assess FB849 plus Keytruda (pembrolizumab) …